var images_info;if (!images_info) images_info =[]; images_info["84"]={"84002":{"type":"graphic_figure","displayName":"Endovascular stent aortic dissection PI","title":"Endovascular stent graft for an aortic dissection","html":"<div class=\"graphic\"><div style=\"width: 549px\" class=\"figure\"><div class=\"ttl\">Endovascular stent graft for an aortic dissection</div><div class=\"cntnt\"><img style=\"width:529px; height:680px;\" src=\"images/PI/84002_Endovascular_stent_aortic_dissection_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An endovascular stent graft is one way to treat an aortic dissection. A \"graft\" is a tube made from manmade materials. For this procedure, the doctor makes a cut in a blood vessel at the top of the thigh. He or she puts a folded graft in the blood vessel and threads it up to the damaged part of the aorta. Then the doctor unfolds the graft. This graft does not need to be sewn into place. Blood flows through the graft.</div><div id=\"graphicVersion\">Graphic 84002 Version 3.0</div></div></div>"},"84004":{"type":"graphic_figure","displayName":"Spirometry PI","title":"Spirometry (breathing test)","html":"<div class=\"graphic\"><div style=\"width: 515px\" class=\"figure\"><div class=\"ttl\">Spirometry (breathing test)</div><div class=\"cntnt\"><img style=\"width:495px; height:434px;\" src=\"images/PI/84004_Spirometry_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Spirometry is a breathing test that measures how well the lungs are working. It involves breathing in as deeply as you can, and then breathing out fast and hard into a mouthpiece. The mouthpiece is attached to a machine called a \"spirometer.\"</div><div class=\"graphic_reference\">Reproduced from: National Heart Lung and Blood Institute. How is COPD diagnosed? Available at: <A spellcheck=true href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/copd/diagnosis\" target=_blank>https://www.nhlbi.nih.gov/health/health-topics/topics/copd/diagnosis</A> (Accessed January 26, 2016).</div><div id=\"graphicVersion\">Graphic 84004 Version 2.0</div></div></div>"},"84005":{"type":"graphic_picture","displayName":"Skin changes face pregnancy PI","title":"Skin changes on the face from pregnancy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Skin changes on the face from pregnancy</div><div class=\"cntnt\"><img style=\"width:378px; height:504px;\" src=\"images/PI/84005_Skin_change_face_preg_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This photo shows an example of skin color changes that can happen with pregnancy.</div><div class=\"graphic_reference\">Reproduced with permission from: <A style=\"FONT-STYLE: italic\" href=\"http://www.visualdx.com/\" target=_blank>www.visualdx.com</A>. Copyright Logical Images, Inc.</div><div id=\"graphicVersion\">Graphic 84005 Version 3.0</div></div></div>"},"84006":{"type":"graphic_diagnosticimage","displayName":"Rhinosinusitis computed tomography","title":"Computed tomography findings in rhinosinusitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Computed tomography findings in rhinosinusitis</div><div class=\"cntnt\"><img style=\"width:399px; height:512px;\" src=\"images/PEDS/84006_Rhinosin_comp_tomogra.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Computed tomography (CT) findings in rhinosinusitis:<br />(A) Coronal CT demonstrating complete opacification of the right ethmoid sinus (arrow) and mucosal thickening of the roof of the right maxillary sinus (arrowhead).<br />(B) Axial CT demonstrating air-fluid level (dashed arrow) in the right maxillary sinus.</div><div class=\"graphic_reference\">Courtesy of Glenn C Isaacson, MD, FAAP, FACS.</div><div id=\"graphicVersion\">Graphic 84006 Version 2.0</div></div></div>"},"84008":{"type":"graphic_figure","displayName":"Insulin pump PI","title":"Insulin pump","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Insulin pump</div><div class=\"cntnt\"><img style=\"width:267px; height:231px;\" src=\"images/PI/84008_Insulin_pump_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">An insulin pump is a device that delivers insulin to a person with diabetes. The insulin goes from the pump, through the tubing, and into the body through a small needle or thin plastic tube. The infusion set is the connection between the tubing and the body.</div><div class=\"graphic_reference\">Reproduced from: US Department of Health and Human Services. National Diabetes Information Clearinghouse: Alternative Devices for Taking Insulin.&nbsp;<A href=\"http://www.niddk.nih.gov/health-information/health-topics/Diabetes/alternative-devices-taking-insulin/Pages/index.aspx\">http://www.niddk.nih.gov/health-information/health-topics/Diabetes/alternative-devices-taking-insulin/Pages/index.aspx</A> (Accessed May 25, 2016)<EM innerHtml>.</EM><A spellcheck=true href=\"http://www.niddk.nih.gov/health-information/health-topics/Diabetes/alternative-devices-taking-insulin/Pages/index.aspx\" target=_blank></A></div><div id=\"graphicVersion\">Graphic 84008 Version 2.0</div></div></div>"},"84010":{"type":"graphic_table","displayName":"Mechanical versus functional intestinal obstruction","title":"Main differences between mechanical versus functional intestinal obstruction","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Main differences between mechanical versus functional intestinal obstruction</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"5\" width=\"20%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Mechanical obstruction</td> <td class=\"subtitle1\">POI</td> <td class=\"subtitle1\">AIPO/ACPO</td> <td class=\"subtitle1\">CIPO</td> </tr> <tr> <td><strong>Luminal obstruction</strong></td> <td>Yes</td> <td>No</td> <td>No</td> <td>No</td> </tr> <tr> <td><strong>Motility</strong></td> <td>Initially &#8593; then &#8595; proximal to obstruction</td> <td>&#8595;</td> <td>&#8595;/uncoordinated</td> <td>&#8595;/uncoordinated</td> </tr> <tr> <td><strong>Dilatation</strong></td> <td>Yes (proximal to obstruction)</td> <td>No</td> <td>Yes</td> <td>Yes</td> </tr> <tr> <td><strong>GI involvement</strong></td> <td>Proximal to obstruction</td> <td>Mainly small bowel</td> <td>Mainly colon</td> <td>Pan-enteric</td> </tr> <tr> <td><strong>Radiology</strong></td> <td>Typical \"cut-off\" point; presence of air-fluid levels</td> <td>\"Cut-off point\" occasionally present; air-fluid levels usually absent</td> <td>\"Cut-off point\" occasionally present; air-fluid levels sometimes detected</td> <td>\"Cut-off point\" occasionally present; air-fluid levels detectable</td> </tr> <tr> <td><strong>Course</strong></td> <td>Acute</td> <td>Acute</td> <td>Acute</td> <td>Chronic</td> </tr> <tr> <td><strong>Progression</strong></td> <td>Rapidly evolving toward total obstruction</td> <td>Self-limiting, slowly improving</td> <td>May respond to medical treatment; major complication may occur</td> <td>Variable, generally self- limiting</td> </tr> <tr> <td><strong>Treatment</strong></td> <td>Surgery</td> <td>Supportive measures</td> <td>Medical treatment (neostigmine); decompressive endoscopy or surgery in unresponsive cases</td> <td>Variable; EN, TPN/HPN often needed</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">&#8593;: increased; &#8595;: decreased; AIPO/ACPO: acute intestinal pseudo-obstruction/acute colonic pseudo-obstruction; CIPO: chronic intestinal pseudo-obstruction; EN: enteral nutrition; GI: gastrointestinal; POI: postoperative ileus; TPN/HPN: total/home parenteral nutrition.</div><div class=\"graphic_reference\">Reproduced from: De Giorgio R, Cogliandro RF, Barbara G, et al. Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. Gastroenterol Clin North Am 2011; 40:787. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 84010 Version 1.0</div></div></div>"},"84011":{"type":"graphic_form","displayName":"Mood timeline","title":"Mood timeline","html":"<div class=\"graphic\"><div style=\"width: 546px\" class=\"figure\"><div class=\"ttl\">Mood timeline</div><div class=\"cntnt\"><img style=\"width:526px; height:444px;\" src=\"images/PSYCH/84011_Mood_timeline.gif\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 84011 Version 3.0</div></div></div>"},"84012":{"type":"graphic_table","displayName":"Bipolar disorder versus ADHD","title":"Bipolar disorder versus attention deficit hyperactive disorder (ADHD)","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Bipolar disorder versus attention deficit hyperactive disorder (ADHD)</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Suspect the presence of bipolar disorder in a child with ADHD if:</td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>The \"ADHD\" symptoms appeared later in life (eg, age 10 years old or older) </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>The symptoms of \"ADHD\" appeared abruptly in an otherwise healthy child </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>The \"ADHD\" symptoms were responding to stimulants and now are not </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>The \"ADHD\" symptoms come and go and tend to occur with mood changes </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>A child with ADHD begins to have periods of exaggerated elation, grandiosity, depression, less need for sleep, or inappropriate sexual behaviors </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>A child with ADHD has recurrent severe mood swings, temper outbursts, or rages </li> </ul> </td> </tr> <tr> <td> <ul class=\"decimal_heading\"> <li>A child with ADHD has hallucinations and/or delusions </li> </ul> </td> </tr> <tr class=\"divider_bottom\"> <td> <ul class=\"decimal_heading\"> <li>A child with ADHD has a strong family history of bipolar disorder in his or her family, particularly if the child is not responding to appropriate ADHD treatments </li> </ul> </td> </tr> <tr> <td>NOTE: A child may have both ADHD and bipolar disorder. In addition, the above noted clinical situations may also be due to other psychiatric disorders (eg, unipolar depression or substance abuse), medical problems (eg, thyroid problems, seizures, or tumors), use of medications (eg, prednisone), and environmental stressors (eg, family conflict, chaotic environment, or sexual or physical abuse) that may coexist with ADHD.</td> </tr> </tbody></table></div><div class=\"graphic_reference\">From NEW HOPE FOR CHILDREN AND TEENS WITH BIPOLAR DISORDER: YOUR FRIENDLY, AUTHORITATIVE GUIDE TO THE LATEST IN TRADITIONAL AND COMPLEMENTARY SOLUTIONS by Boris Birmaher, copyright &copy; 2004 by Boris Birmaher. Used by permission of Three Rivers Press, a division of Random House, Inc. Any third party use of this material, outside of this publication, is prohibited. Interested parties must apply directly to Random House, Inc. for permission.<br />For online information about other Random House, Inc. books and authors, see the Internet Web Site at <a href=\"http://www.randomhouse.com/\" target=\"_blank\">http://www.randomhouse.com</a>.</div><div id=\"graphicVersion\">Graphic 84012 Version 2.0</div></div></div>"},"84014":{"type":"graphic_table","displayName":"Helminths with eosinophilia","title":"Helminth infections associated with marked and/or persistent eosinophilia parasitic disease development and duration","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Helminth infections associated with marked and/or persistent eosinophilia parasitic disease development and duration</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Parasitic disease organism(s)</td> <td class=\"subtitle1\" colspan=\"2\">Development and duration of eosinophilia</td> <td class=\"subtitle1\" rowspan=\"2\">Main anatomical site(s)</td> <td class=\"subtitle1\" rowspan=\"2\">Diagnosis</td> </tr> <tr> <td class=\"subtitle2\">Acute</td> <td class=\"subtitle2\">Persistent</td> </tr> <tr> <td colspan=\"5\"><strong>Angiostrongyloidiasis</strong></td> </tr> <tr> <td class=\"indent1\"><em>Angiostrongylus cantonensis</em></td> <td class=\"centered\">+</td> <td class=\"centered\">&nbsp;</td> <td>CNS</td> <td>Larvae in CSF</td> </tr> <tr> <td class=\"indent1\"><em>Angiostrongylus costaricensis</em></td> <td class=\"centered\">+</td> <td class=\"centered\">&nbsp;</td> <td>GI</td> <td>Biopsy</td> </tr> <tr> <td><strong>Ascariasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">&nbsp;</td> <td>GI</td> <td>Eggs in stool</td> </tr> <tr> <td><strong>Clonorchiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Hepatobiliary</td> <td>Eggs in stool, serology</td> </tr> <tr> <td><strong>Fascioliasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Hepatobiliary</td> <td>Eggs in stool, serology</td> </tr> <tr> <td><strong>Fasciolopsiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">&nbsp;</td> <td>GI</td> <td>Eggs in stool</td> </tr> <tr> <td colspan=\"5\"><strong>Filarial infections</strong></td> </tr> <tr> <td class=\"indent1\">Lymphatic filariasis<br /> <em>(Brugia, Wuchereria)</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Blood, lymphatics</td> <td>Mf in blood, serology, CFA</td> </tr> <tr> <td class=\"indent1\"><em>Loa loa</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Subcutaneous, eye</td> <td>Mf in blood, worm extracted</td> </tr> <tr> <td class=\"indent1\"><em>Mansonella ozzardi</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Blood</td> <td>Mf in blood</td> </tr> <tr> <td class=\"indent1\"><em>Mansonella perstans</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Blood, body cavities</td> <td>Mf in blood, adult in tissue</td> </tr> <tr> <td class=\"indent1\"><em>Mansonella streptocerca</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Skin, subcutaneous tissue</td> <td>Mf in skin snips</td> </tr> <tr> <td class=\"indent1\"><em>Onchocerca volvulus</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Skin, eye, subcutaneous tissue</td> <td>Mf in skin snips, adults in nodules</td> </tr> <tr> <td><strong>Tropical pulmonary eosinophilia</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Lung</td> <td>Serology</td> </tr> <tr> <td><strong>Gnathostomiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Soft tissue</td> <td>Serology, worm in specimen</td> </tr> <tr> <td><strong>Hookworm</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>GI, lung (acutely)</td> <td>Eggs in stool</td> </tr> <tr> <td><strong>Opisthorchiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Hepatobiliary</td> <td>Eggs in stool</td> </tr> <tr> <td><strong>Paragonimiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Lung, CNS, subcutaneous</td> <td>Eggs in sputum, BAL, stool</td> </tr> <tr> <td><strong>Schistosomiasis</strong></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>Serology</td> </tr> <tr> <td class=\"indent1\"><em>Schistosoma haematobium</em></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>Urinary tract</td> <td>Eggs in urine, serology</td> </tr> <tr> <td class=\"indent1\"><em>Schistosoma intercalatum</em></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>Hepatic, GI</td> <td>Eggs in stool</td> </tr> <tr> <td class=\"indent1\"><em>Schistosoma japonicum</em></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>Hepatic, GI</td> <td>Eggs in stool</td> </tr> <tr> <td class=\"indent1\"><em>Schistosoma mansoni</em></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>Hepatic, GI</td> <td>Eggs in stool, serology</td> </tr> <tr> <td class=\"indent1\"><em>Schistosoma mekongi</em></td> <td class=\"centered\">+</td> <td>&nbsp;</td> <td>Hepatic, GI</td> <td>Eggs in stool</td> </tr> <tr> <td><strong>Strongyloidiasis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>GI, lung, skin</td> <td>Larvae in stool, serology</td> </tr> <tr> <td><strong>Trichinosis</strong></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>GI, muscle</td> <td>Serology, muscle biopsy</td> </tr> <tr> <td colspan=\"5\"><strong>Visceral larva migrans</strong></td> </tr> <tr> <td class=\"indent1\"><em>Toxocara canis; T. catis</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>Liver, eye, lung</td> <td>Serology, larvae in tissue</td> </tr> <tr> <td class=\"indent1\"><em>Baylisascaris procyonis</em></td> <td class=\"centered\">+</td> <td class=\"centered\">+</td> <td>CNS, eye</td> <td>Larvae in specimen</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">CNS: central nervous system; CSF: cerebrospinal fluid; GI: gastrointestinal; Mf: microfilariae; CFA: circulating filarial antigen; BAL: bronchoalveolar lavage.</div><div class=\"graphic_reference\">Reproduced from: Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol 2012; 49:149. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 84014 Version 2.0</div></div></div>"},"84015":{"type":"graphic_table","displayName":"Drugs and eosinophilia","title":"Types of drug reactions associated with eosinophilia","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Types of drug reactions associated with eosinophilia</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"2\" width=\"50%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">Manifestations</td> <td class=\"subtitle1\">Commonly associated drugs</td> </tr> <tr> <td class=\"sublist1_start\">Asymptomatic</td> <td>Penicillins, cephalosporins</td> </tr> <tr> <td>Soft tissue swelling</td> <td>GM-CSF, IL-2</td> </tr> <tr> <td>Pulmonary infiltrates</td> <td>NSAIDs</td> </tr> <tr> <td>Interstitial nephritis</td> <td>Semisynthetic penicillins, cephalosporins, NSAIDs</td> </tr> <tr> <td>Myocarditis</td> <td>Ranitidine</td> </tr> <tr> <td>Hepatitis</td> <td>Semisynthetic penicillins, tetracyclines</td> </tr> <tr> <td>Hypersensitivity vasculitis</td> <td>Allopurinol, phenytoin</td> </tr> <tr> <td>Gastroenterocolitis</td> <td>NSAIDs</td> </tr> <tr> <td>Asthma, nasal polyps</td> <td>Aspirin</td> </tr> <tr> <td class=\"sublist1_start\">Eosinophilia-myalgia syndrome</td> <td>L-tryptophan contaminant</td> </tr> <tr> <td>DRESS</td> <td>Sulfasalazine, phenytoin, carbamazepine, allopurinol, hydrochlorothiazide, cyclosporine, nevirapine</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">GM-CSF: granulocyte-macrophage colony-stimulating factor; IL-2: interleukin-2; NSAIDs: nonsteroidal antiinflammatory drugs; DRESS: drug reaction with eosinophilia and systemic symptoms.</div><div class=\"graphic_reference\">Original figure modified for this publication. Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol 2012; 49:149. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id=\"graphicVersion\">Graphic 84015 Version 3.0</div></div></div>"},"84016":{"type":"graphic_table","displayName":"Diseases with organ eosinophils","title":"Eosinophilic diseases that may present with organ-restricted involvement ","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Eosinophilic diseases that may present with organ-restricted involvement </div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td class=\"subtitle1_single\">Skin and subcutaneous diseases</td> </tr> <tr> <td>Atopic dermatitis</td> </tr> <tr> <td>Eosinophilic panniculitis</td> </tr> <tr> <td>Episodic angioedema with eosinophilia</td> </tr> <tr> <td>Angiolymphoid hyperplasia with eosinophilia (and Kimura's disease)</td> </tr> <tr> <td>Eosinophilic fasciitis</td> </tr> <tr> <td>Eosinophilic cellulitis (Wells syndrome)</td> </tr> <tr> <td>Angiolymphoid hyperplasia with eosinophilia (and Kimura's disease)</td> </tr> <tr> <td>Eosinophilic pustular folliculitis</td> </tr> <tr> <td>Recurrent cutaneous necrotizing eosinophilic vasculitis</td> </tr> <tr> <td>Eosinophilic ulcer of the oral mucosa&nbsp;</td> </tr> <tr> <td class=\"subtitle1_single\">Sinonasal and pulmonary diseases</td> </tr> <tr> <td>&nbsp;Allergic rhinitis</td> </tr> <tr> <td>&nbsp;Chronic rhinosinusitis</td> </tr> <tr> <td>&nbsp;Asthma</td> </tr> <tr> <td>Drug- and toxin-induced eosinophilic lung diseases</td> </tr> <tr> <td>Helminth-associated (Loeffler syndrome; tropical pulmonary eosinophilia)</td> </tr> <tr> <td>Chronic eosinophilic pneumonia</td> </tr> <tr> <td>Acute eosinophilic pneumonia</td> </tr> <tr> <td>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)</td> </tr> <tr> <td>Other vasculitides</td> </tr> <tr> <td class=\"subtitle1_single\">Gastrointestinal diseases</td> </tr> <tr> <td class=\"sublist1_start\">Eosinophilic gastrointestinal disorders (EGIDs)</td> </tr> <tr> <td class=\"sublist1\">Eosinophilic esophagitis, eosinophilic gastroenteritis, eosinophilic cholangitis, eosinophilic cholecystitis&nbsp;&nbsp;</td> </tr> <tr> <td>Primary biliary cirrhosis</td> </tr> <tr> <td>Sclerosing cholangitis</td> </tr> <tr> <td>Eosinophilic cholangitis</td> </tr> <tr> <td>Eosinophilic cholecystitis</td> </tr> <tr> <td>Hepatic eosinophilia due to semisynthetic penicillins or tetracyclines</td> </tr> <tr> <td>&nbsp;Hepatic transplant rejection</td> </tr> <tr> <td class=\"subtitle1_single\">Neurologic diseases</td> </tr> <tr> <td>Eosinophilic meningitis</td> </tr> <tr> <td>Ventriculoperitoneal shunts</td> </tr> <tr> <td>Leukemia or lymphoma with CNS involvement (Hodgkin)</td> </tr> <tr> <td>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)</td> </tr> <tr> <td class=\"subtitle1_single\">Rheumatologic diseases</td> </tr> <tr> <td>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)</td> </tr> <tr> <td>Other vasculitides</td> </tr> <tr> <td>Eosinophilia-myalgia syndrome</td> </tr> <tr> <td class=\"subtitle1_single\">Cardiac diseases</td> </tr> <tr> <td>Hypersensitivity myocarditis</td> </tr> <tr> <td>&nbsp;Parasitic infections</td> </tr> <tr> <td>&nbsp;Hypereosinophilic syndromes</td> </tr> <tr> <td>Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)</td> </tr> <tr> <td class=\"subtitle1_single\">Genitourinary disease</td> </tr> <tr> <td>Drug-induced interstitial nephritis</td> </tr> <tr> <td>Eosinophilic cystitis, eosinophilic prostatitis</td> </tr> <tr> <td>&nbsp;Renal transplant rejection</td> </tr> <tr> <td>&nbsp;Schistosomiasis</td> </tr> <tr> <td>&nbsp;Hemodialysis and peritoneal dialysis</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">The disorders listed above can present with organ-specific dysfunction, accompanied by eosinophilic infiltration of the involved tissues. Peripheral blood eosinophilia is variable. This list of disorders is not exhaustive. </div><div class=\"graphic_footnotes\">CNS: central nervous system. </div><div id=\"graphicVersion\">Graphic 84016 Version 5.0</div></div></div>"},"84018":{"type":"graphic_table","displayName":"Bipolar disorder vs oppositional defiant or conduct disorder","title":"Bipolar disorder versus oppositional defiant disorder or conduct disorder","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Bipolar disorder versus oppositional defiant disorder or conduct disorder</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr class=\"divider_bottom\"> <td>If the behavior problems <strong>only</strong> occur while the child is in the midst of an episode of mania or depression, and the behavior problems disappear when the mood symptoms improve, the diagnoses of oppositional or conduct disorder should not be made.</td> </tr> <tr class=\"divider_bottom\"> <td>If a child has \"off and on\" oppositional or conduct symptoms, or these symptoms only appear when the child has mood problems, the diagnosis of bipolar disorder (or other disorders such as recurrent unipolar depression or substance abuse) should be considered.</td> </tr> <tr class=\"divider_bottom\"> <td>If the child had oppositional behaviors before the onset of the mood disorders, both diagnoses may be given.</td> </tr> <tr class=\"divider_bottom\"> <td>If a child has severe behavior problems that are not responding to treatment, consider the possibility of a mood disorder (bipolar and non-bipolar depressions), other psychiatric disorder (eg, ADHD or substance abuse), and/or exposure to stressors.</td> </tr> <tr class=\"divider_bottom\"> <td>If a child has behavior problems and a family history of bipolar disorder, consider the possibility that the child has a mood disorder (unipolar major depression or bipolar disorder).</td> </tr> <tr> <td>If a child has behavior problems and is having hallucinations and delusions, consider the possibility of bipolar disorder. Also consider the possibility of schizophrenia, use of illicit drugs/alcohol, or medical/neurological conditions.</td> </tr> </tbody></table></div><div class=\"graphic_reference\">From NEW HOPE FOR CHILDREN AND TEENS WITH BIPOLAR DISORDER: YOUR FRIENDLY, AUTHORITATIVE GUIDE TO THE LATEST IN TRADITIONAL AND COMPLEMENTARY SOLUTIONS by Boris Birmaher, copyright &copy; 2004 by Boris Birmaher. Used by permission of Three Rivers Press, a division of Random House, Inc. Any third party use of this material, outside of this publication, is prohibited. Interested parties must apply directly to Random House, Inc. for permission.<br />For online information about other Random House, Inc. books and authors, see the Internet Web Site at <a href=\"http://www.randomhouse.com/\" target=\"_blank\">http://www.randomhouse.com</a>.</div><div id=\"graphicVersion\">Graphic 84018 Version 2.0</div></div></div>"},"84019":{"type":"graphic_figure","displayName":"Hand-assisted laparoscopic approach","title":"Hand-assisted laparoscopic approach","html":"<div class=\"graphic\"><div style=\"width: 544px\" class=\"figure\"><div class=\"ttl\">Hand-assisted laparoscopic approach</div><div class=\"cntnt\"><img style=\"width:524px; height:533px;\" src=\"images/SURG/84019_Hand-assisted-laparoscopic-approach.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure depicts the nondominant hand inserted through a hand-assisted device when performing a complicated laparoscopic procedure. The hand-assisted port is inserted through a mini-laparotomy-sized incision.</div><div id=\"graphicVersion\">Graphic 84019 Version 2.0</div></div></div>"},"84020":{"type":"graphic_picture","displayName":"Port placement for hand-assisted laparoscopic devices","title":"Port placement for hand-assisted laparoscopic devices","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Port placement for hand-assisted laparoscopic devices</div><div class=\"cntnt\"><img style=\"width:504px; height:311px;\" src=\"images/SURG/84020_Port_place_hand_laporscp.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This figure shows placement of a laparoscopic device at the ileostomy site, umbilicus, and lateral abdomen. The hand-assisted device (seen as the blue apparatus), allows for insertion of the nondominant hand into the abdomen through a suprapubic incision.</div><div id=\"graphicVersion\">Graphic 84020 Version 2.0</div></div></div>"},"84022":{"type":"graphic_picture","displayName":"Matured Brooke end ileostomy","title":"Matured Brooke end ileostomy","html":"<div class=\"graphic\"><div style=\"width: 522px\" class=\"figure\"><div class=\"ttl\">Matured Brooke end ileostomy</div><div class=\"cntnt\"><img style=\"width:502px; height:377px;\" src=\"images/SURG/84022_Mat_Brooke_end_ileostomy.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">This picture shows the matured Brooke end ileostomy.</div><div id=\"graphicVersion\">Graphic 84022 Version 3.0</div></div></div>"},"84023":{"type":"graphic_figure","displayName":"Tumor evolution in AML","title":"Examples of the two major patterns of tumor evolution in acute myeloid leukemia","html":"<div class=\"graphic\"><div style=\"width: 742px\" class=\"figure\"><div class=\"ttl\">Examples of the two major patterns of tumor evolution in acute myeloid leukemia</div><div class=\"cntnt\"><img style=\"width:722px; height:432px;\" src=\"images/HEME/84023_Tumor_evolution_in_AML.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Model 1 shows the dominant clone in the primary tumor evolving into the relapse clone by gaining relapse specific mutations; this pattern was identified in three primary tumor and relapse pairs. Model 2 shows a minor clone carrying the vast majority of the primary tumor mutations survived and expanded at relapse. This pattern was observed in five primary tumor and relapse pairs.</div><div class=\"graphic_footnotes\">AML: acute myeloid leukemia; HSCs: hematopoietic stem cells.</div><div class=\"graphic_reference\">Reprinted by permission from: Macmillan Publishers Ltd: Nature 2012; 481:506. Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole-genome sequencing. Copyright &copy; 2012.</div><div id=\"graphicVersion\">Graphic 84023 Version 1.0</div></div></div>"},"84024":{"type":"graphic_diagnosticimage","displayName":"Acute HP chest radiograph","title":"Acute hypersensitivity pneumonitis","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Acute hypersensitivity pneumonitis</div><div class=\"cntnt\"><img style=\"width:398px; height:451px;\" src=\"images/PULM/84024_Acute_HP_chest_radiograph.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Chest radiograph of a patient with acute pigeon breeder's disease. Note bilateral lower lobe nodular opacities.</div><div class=\"graphic_reference\">Reproduced with permission from: Schuyler M. Hypersensitivity pneumonitis. In: Baum's Textbook of Pulmonary Disease, 7th ed, Crapo JD, Glassroth J, Karlinsky JB, King TE (Eds). Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.</div><div id=\"graphicVersion\">Graphic 84024 Version 2.0</div></div></div>"},"84025":{"type":"graphic_table","displayName":"Continuation or discontinuation of anticoagulation","title":"2012 ACCP guidelines for continuation or discontinuation of anticoagulation after the first three months","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">2012 ACCP guidelines for continuation or discontinuation of anticoagulation after the first three months</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\" rowspan=\"2\">Thrombotic recurrence risk group</td> <td class=\"subtitle1\" colspan=\"3\">Bleeding risk group*</td> </tr> <tr> <td class=\"subtitle2\">Low</td> <td class=\"subtitle2\">Intermediate</td> <td class=\"subtitle2\">High</td> </tr> <tr> <td>First VTE provoked by surgery</td> <td>Discontinue (strong)</td> <td>Discontinue (strong)</td> <td>Discontinue (strong)</td> </tr> <tr> <td>First VTE provoked by non-surgical factor or first unprovoked distal DVT</td> <td>Discontinue (weak)</td> <td>Discontinue (weak)</td> <td>Discontinue (strong)</td> </tr> <tr> <td>First unprovoked proximal DVT or PE</td> <td>Continue (weak)</td> <td>Continue (weak)</td> <td>Discontinue (strong)</td> </tr> <tr> <td>Second unprovoked VTE</td> <td>Continue (strong)</td> <td>Continue (weak)</td> <td>Discontinue (weak)</td> </tr> </tbody></table></div><div class=\"graphic_lgnd\">The strength of the recommendation to continue or discontinue is noted in parentheses.</div><div class=\"graphic_footnotes\">VTE: venous thromboembolism; DVT: deep vein thrombosis; PE: pulmonary embolism. <br />* The 2012 ACCP bleeding risk model assumes risk of major bleeding after the first three months of anticoagulation as 0.8, 1.6, and &ge;6.5 percent for the low, intermediate, and high risk groups, respectively.</div><div class=\"graphic_reference\">Modified from: Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.</div><div id=\"graphicVersion\">Graphic 84025 Version 1.0</div></div></div>"},"84026":{"type":"graphic_figure","displayName":"Adaptive servo-ventilation","title":"Principles of operation of adaptive servo-ventilation","html":"<div class=\"graphic\"><div style=\"width: 506px\" class=\"figure\"><div class=\"ttl\">Principles of operation of adaptive servo-ventilation</div><div class=\"cntnt\"><img style=\"width:486px; height:370px;\" src=\"images/PULM/84026_Adapt_servo_ventilation.gif\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">Principles of operation of servo-ventilation are depicted.<br />The airflow tracing (top) depicts a classical crescendo (orange arrow) and decrescendo (red arrow) pattern of Cheyne-Stokes breathing, followed by an ensuing central apnea. The servo-controlled automatic adjustment of the inspiratory positive airway pressure (IPAP) level is inversely related to the changes in peak flow levels over a moving time window (bottom). Specifically, during the crescendo pattern of peak flow rates (orange arrow), the pressure assist (or IPAP) level decreases in order to dampen the rise in inspiratory peak flow rate (or tidal volume). Conversely, during the decrescendo pattern of peak flow rates (red arrow), the pressure assist (or IPAP) level increases in order to dampen the fall in inspiratory peak flow rate (or tidal volume). Therefore, the servo system dampens the inherent oscillatory behavior of the patient's breathing pattern and smoothes respiration. During a central apnea, the device's backup rate becomes active and ventilates the patient (bottom).<br />The IPAP level is depicted in centimeters of H<SUB>2</SUB>O with a maximum IPAP (IPAPmax) set at 17 cm H<SUB>2</SUB>O and a minimum IPAP (IPAPmin) set at 9 cm H<SUB>2</SUB>O (horizontal interrupted blue lines). The expiratory positive airway pressure (EPAP) level was set at 7 cm H<SUB>2</SUB>O. The pressure assist or pressure support level is equal to the IPAP minus EPAP level.</div><div class=\"graphic_reference\">Reproduced with permission from: Antonescu-Turcu A, Parthasarathy S. CPAP and bi-level PAP therapy: new and established roles. Respir Care 2010; 55:1216. Copyright &copy; 2010 American Association for Respiratory Care. All rights reserved.</div><div id=\"graphicVersion\">Graphic 84026 Version 2.0</div></div></div>"},"84027":{"type":"graphic_table","displayName":"Treatment-emergent central sleep apnea contributors","title":"Features associated with, or contributing to, appearance of central apneas in treatment-emergent central sleep apnea","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Features associated with, or contributing to, appearance of central apneas in treatment-emergent central sleep apnea</div><div class=\"cntnt\"><table cellspacing=\"0\"><tbody> <tr> <td>Non-rapid eye movement (REM) sleep</td> </tr> <tr> <td>Severe OSA</td> </tr> <tr> <td>Supine position</td> </tr> <tr> <td>Higher CPAP levels (\"over-titration\")</td> </tr> <tr> <td>Higher pressure support level</td> </tr> <tr> <td>Altitude</td> </tr> <tr> <td>Oral breathing</td> </tr> <tr> <td>Opioid narcotics</td> </tr> <tr> <td>Congestive heart failure</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">CPAP: continuous positive airway pressure; OSA: obstructive sleep apnea.</div><div id=\"graphicVersion\">Graphic 84027 Version 5.0</div></div></div>"},"84032":{"type":"graphic_picture","displayName":"Edematous ectopy","title":"Edematous ectopy","html":"<div class=\"graphic\"><div style=\"width: 470px\" class=\"figure\"><div class=\"ttl\">Edematous ectopy</div><div class=\"cntnt\"><img style=\"width:324px; height:504px;\" src=\"images/ID/84032_Edematous_ectopy.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of Seattle STD/HIV Prevention Training Center (Claire Stevens, photographer).</div><div id=\"graphicVersion\">Graphic 84032 Version 1.0</div></div></div>"},"84033":{"type":"graphic_picture","displayName":"Chlamydia conjunctivitis","title":"Chlamydia conjunctivitis","html":"<div class=\"graphic\"><div style=\"width: 524px\" class=\"figure\"><div class=\"ttl\">Chlamydia conjunctivitis</div><div class=\"cntnt\"><img style=\"width:504px; height:369px;\" src=\"images/ID/84033_Chlamydia_conjunctivitis.jpg\" alt=\"Image\"/></div><div class=\"graphic_reference\">Courtesy of the Seattle STD/HIV Prevention Training Center.</div><div id=\"graphicVersion\">Graphic 84033 Version 1.0</div></div></div>"},"84036":{"type":"graphic_picture","displayName":"Detached retina PI","title":"Detached retina","html":"<div class=\"graphic\"><div style=\"width: 568px\" class=\"figure\"><div class=\"ttl\">Detached retina</div><div class=\"cntnt\"><img style=\"width:548px; height:340px;\" src=\"images/PI/84036_Detached_retina_PI.jpg\" alt=\"Image\"/></div><div class=\"graphic_lgnd\">The retina is the tissue at the back of the eye. If it gets a tear or hole, it can start to come off the back of the eye. This causes vision changes. It can cause vision loss or even blindness.</div><div id=\"graphicVersion\">Graphic 84036 Version 1.0</div></div></div>"},"84043":{"type":"graphic_table","displayName":"COPD medicines PI","title":"Medicines for COPD","html":"<div class=\"graphic\"><div class=\"figure\"><div class=\"ttl\">Medicines for COPD</div><div class=\"cntnt\"><table cellspacing=\"0\"><colgroup span=\"4\" width=\"25%\"></colgroup> <tbody> <tr> <td class=\"subtitle1\">&nbsp;</td> <td class=\"subtitle1\">Generic name</td> <td class=\"subtitle1\">Sample US brand names</td> <td class=\"subtitle1\">How it's given</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"2\"><strong>Short-acting beta agonists (SABAs)</strong></td> <td>Albuterol</td> <td>ProAir HFA, Proventil HFA, ProAir RespiClick, Ventolin HFA, AccuNeb</td> <td>Metered dose inhaler,* dry powder inhaler, nebulizer</td> </tr> <tr class=\"divider_bottom\"> <td>Levalbuterol</td> <td>Xopenex HFA</td> <td>Metered dose inhaler,* nebulizer</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Short-acting anticholinergics</strong></td> <td>Ipratropium</td> <td>Atrovent HFA</td> <td>Metered dose inhaler,* nebulizer</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Short-acting combination</strong></td> <td>Albuterol and ipratropium</td> <td>Combivent Respimat, DuoNeb</td> <td>Soft mist inhaler,<sup>&#182;</sup> nebulizer</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"5\"><strong>Long-acting beta agonists</strong></td> <td>Arformoterol</td> <td>Brovana</td> <td>Nebulizer</td> </tr> <tr> <td>Formoterol</td> <td>Perforomist</td> <td>Nebulizer</td> </tr> <tr> <td>Indacaterol</td> <td>Arcapta Neohaler</td> <td>Single-dose dry powder inhaler (medicine comes in a pill that you put into the inhaler when it's time to take a dose). Use only once a day.</td> </tr> <tr> <td>Olodaterol</td> <td>Striverdi Respimat</td> <td>Soft mist inhaler<sup>&#182;</sup></td> </tr> <tr class=\"divider_bottom\"> <td>Salmeterol</td> <td>Serevent Diskus</td> <td>Dry powder inhaler</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"5\"><strong>Long-acting anticholinergic</strong></td> <td>Aclidinium</td> <td>Tudorza Pressair</td> <td>Dry powder inhaler (must be used twice a day)</td> </tr> <tr> <td>Glycopyrrolate (glycopyrronium)</td> <td>Seebri Neohaler</td> <td>Single-dose dry powder inhaler (medicine comes in a pill that you put into the inhaler when it is time to take a dose)</td> </tr> <tr> <td rowspan=\"2\">Tiotropium</td> <td>Spiriva HandiHaler</td> <td>Single-dose dry powder inhaler (medicine comes in a pill that you put into the inhaler when it's time to take a dose)</td> </tr> <tr> <td>Spiriva Respimat</td> <td>Soft mist inhaler<sup>&#182;</sup></td> </tr> <tr class=\"divider_bottom\"> <td>Umeclidinium</td> <td>Incruse Ellipta</td> <td>Dry powder inhaler</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"6\"><strong>Inhaled steroid medicines</strong></td> <td>Beclomethasone</td> <td>QVAR</td> <td>Metered dose inhaler*</td> </tr> <tr> <td>Budesonide</td> <td>Pulmicort Flexhaler, Pulmicort</td> <td>Dry powder inhaler, nebulizer</td> </tr> <tr> <td>Ciclesonide</td> <td>Alvesco</td> <td>Metered dose inhaler*</td> </tr> <tr> <td>Fluticasone furoate</td> <td>Arnuity Ellipta</td> <td>Dry powder inhaler</td> </tr> <tr> <td>Fluticasone propionate</td> <td>Flovent Diskus, Flovent HFA</td> <td>Dry powder inhaler, metered dose inhaler*</td> </tr> <tr class=\"divider_bottom\"> <td>Mometasone</td> <td>Asmanex Twisthaler, Asmanex HFA</td> <td>Dry powder inhaler, metered dose inhaler*</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"4\"><strong>Long-acting beta agonist and steroid combinations</strong></td> <td>Budesonide and formoterol</td> <td>Symbicort</td> <td>Metered dose inhaler*</td> </tr> <tr> <td>Fluticasone and salmeterol</td> <td>Advair Diskus, Advair HFA</td> <td>Dry powder inhaler, metered dose inhaler*</td> </tr> <tr> <td>Fluticasone and vilanterol</td> <td>Breo Ellipta</td> <td>Dry powder inhaler</td> </tr> <tr class=\"divider_bottom\"> <td>Mometasone and formoterol</td> <td>Dulera</td> <td>Metered dose inhaler*</td> </tr> <tr> <td class=\"divider_bottom\" rowspan=\"3\"><strong>Long-acting beta-agonist and anticholinergic combinations</strong></td> <td>Glycopyrrolate (glycopyrronium) and indacaterol</td> <td>Utibron Neohaler</td> <td>Single-dose dry powder inhaler (medicine comes in a pill that you put into the inhaler when it is time to take a dose)</td> </tr> <tr> <td>Tiotropium and olodaterol</td> <td>Stiolto Respimat</td> <td>Soft mist inhaler<sup>&#182;</sup></td> </tr> <tr class=\"divider_bottom\"> <td>Umeclidinium and vilanterol</td> <td>Anoro Ellipta</td> <td>Dry powder inhaler</td> </tr> <tr class=\"divider_bottom\"> <td><strong>Roflumilast</strong></td> <td>Roflumilast</td> <td>Daliresp</td> <td>Pill</td> </tr> <tr> <td><strong>Theophylline</strong></td> <td>Theophylline</td> <td>Theo-24, Theochron</td> <td>Pill or IV</td> </tr> </tbody></table></div><div class=\"graphic_footnotes\">* Metered dose inhalers must be primed before first use, if not used for a week or 2 (depending on the brand), or if dropped. Priming a metered dose inhaler usually involves shaking it and spraying it into the air (away from your face) up to 4 times. See the information that came with your inhaler for exact instructions.<br />&para; Respimat inhalers must be primed before first use or if not used for more than 21 days. To prime, point the inhaler at the ground, push the button a few times until you see a cloud of medicine, and then push the button 3 more times. Also, if you go more than 3 days without using Respimat, spray it 1 time at the ground before using it.</div><div id=\"graphicVersion\">Graphic 84043 Version 8.0</div></div></div>"},"84656":{"type":"graphic_figure","displayName":"Proctocolectomy for cancer and division of lateral ligaments","title":"Proctocolectomy for cancer and division of lateral ligaments","html":"<div class=\"graphic\"><div style=\"width: 533px\" class=\"figure\"><div class=\"ttl\">Proctocolectomy for cancer and division of lateral ligaments</div><div class=\"cntnt\"><img style=\"width:513px; height:486px;\" src=\"images/SURG/84656_lateral-ligament-cancer.jpg\" alt=\"Image\"/></div><div id=\"graphicVersion\">Graphic 84656 Version 2.0</div></div></div>"}};